The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
Publication ID
PEP21-02-01-003
Publication Date
August 2021
Format
More like this TIP Series - Treatment Improvement Protocols (TIPS)
Order Print Publication
Max Order Limit
10